Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Feasibility Study to Evaluate the Observance Rehabilitation of Upper Limbs by Visual-motor Simulation Associated at Transcranial Direct Current Stimulation (tDCS) in Hemiparetic Patient Post-stroke (SIMSTIM)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03815266
Recruitment Status : Recruiting
First Posted : January 24, 2019
Last Update Posted : January 24, 2019
Sponsor:
Information provided by (Responsible Party):
Centre Hospitalier Universitaire de Saint Etienne

Brief Summary:
Although the mirror therapy is recognized as effective, its practice is difficult, especially with hemiplegic patients. It is difficult for them to understand, control the movements and carry out a double task with the two upper limbs. The implementation of a Computerized Mirror Therapy (CMT) with the Intensive Visual Simulation 3 (IVS3) device makes it possible to limit these problems by proposing pre-recorded sessions, not limited to the right or left hemi-space, and proposing a work on proximal motricity. Since the functional prognosis of the upper hemiplegic limb remains mostly unfavourable, a wide range of interventions should be proposed. There is currently a consensus to consider the use of transcranial Direct Current Stimulation (tDCS) stimulation in functional recovery after stroke as a method to enhance the effectiveness of training techniques. Although all motor therapies can theoretically benefit from increased effectiveness by the addition of transcranial Direct Current Stimulation (tDCS), Computerized Mirror Therapy (CMT) has a high potential for sensitivity to transcranial Direct Current Stimulation (tDCS) due to the intensity of the motor training of the upper limb applied.

Condition or disease Intervention/treatment Phase
Stroke Diagnostic Test: transcranial Direct Current Stimulation (tDCS) Diagnostic Test: Computerized Mirror Therapy (CMT) Diagnostic Test: Tolerance Assessment Questionnaire Diagnostic Test: Ashworth's scale Diagnostic Test: Frenchay arm test Diagnostic Test: Abilhand questionnaire Diagnostic Test: Fugl-Meyer test Diagnostic Test: Goal Attainment Scaling (GAS) Not Applicable

Detailed Description:
The primary objective of this study is to investigate the feasibility of a program combining Computerized Mirror Therapy (CMT) with dual- transcranial Direct Current Stimulation (tDCS) stimulation by evaluating observance to hemiparetic stroke patients.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 20 participants
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Supportive Care
Official Title: Feasibility Study to Evaluate the Observance Rehabilitation of Upper Limbs by Visual-motor Simulation Associated at Transcranial Direct Current Stimulation (tDCS) in Hemiparetic Patient Post-stroke.
Actual Study Start Date : September 20, 2018
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : March 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Rehabilitation

Arm Intervention/treatment
Experimental: Patient with first ischemic or hemorrhagic stroke

Patient with first ischemic or hemorrhagic stroke will be included. They will have the following program Computerized Mirror Therapy (CMT) associated at transcranial Direct Current Stimulation (tDCS). This program will consist of 5 sessions per week for 4 weeks (20 minutes).

In more, they will have the following tests: Tolerance Assessment Questionnaire, Ashworth's scale, Frenchay arm test, Abilhand questionnaire, Fugl-Meyer test, and Goal Attainment Scaling (GAS).

Diagnostic Test: transcranial Direct Current Stimulation (tDCS)

transcranial Direct Current Stimulation (tDCS) is device which consist in setting up an electrode on the skull of the patient to deliver the low intensity current.

Patient will have transcranial Direct Current Stimulation (tDCS) at each session and at the same time of Computerized Mirror Therapy (CMT).


Diagnostic Test: Computerized Mirror Therapy (CMT)
Computerized Mirror Therapy (CMT) will be realizing by the device Intensive Visual Simulation 3 (IVS3). Patient will have Computerized Mirror Therapy (CMT) at each session and at the same time of transcranial Direct Current Stimulation (tDCS).
Other Name: Intensive Visual Simulation3 (IVS3)

Diagnostic Test: Tolerance Assessment Questionnaire
The Tolerance Assessment Questionnaire will be completed at the end of each session.

Diagnostic Test: Ashworth's scale
Ashworth's scale evaluates the resistance to stretching. This test will be completed before the start of the program, at the end of the program and one month after.

Diagnostic Test: Frenchay arm test

Frenchay arm test evaluates your abilities with the affected hand to perform several actions.

This test will be completed before the start of the program, at the end of the program and one month after.


Diagnostic Test: Abilhand questionnaire

Abilhand questionnaire evaluates your abilities to perform several activities in the daily life with your arm affected.

This test will be completed before the start of the program, at the end of the program and one month after.


Diagnostic Test: Fugl-Meyer test

Fugl-Meyer test evaluates your ability to perform different movements with all the joints of your arm affected.

This test will be completed before the start of the program, at the end of the program and one month after.


Diagnostic Test: Goal Attainment Scaling (GAS)

Goal Attainment Scaling (GAS) sets therapeutic goals with the patient before the start of the program.

These goals will be checked at the end of the program and one month after.





Primary Outcome Measures :
  1. Rate of observance of the program Computerized Mirror Therapy (CMT) + transcranial Direct Current Stimulation (tDCS) [ Time Frame: Up to Day 40 ]
    Rate of observance of the program CMT + tDCS. It is will be measured by the number of patients who will be finished the study.


Secondary Outcome Measures :
  1. Effect of the program Computerized Mirror Therapy (CMT) + transcranial Direct Current Stimulation (tDCS) improving activities of the upper limb - measured by Frenchay arm test [ Time Frame: Day 40 ]

    To evaluate the effect of the program Computerized Mirror Therapy (CMT) + transcranial Direct Current Stimulation (tDCS) improving activities of the upper limb.

    It is will be measured by Frenchay arm test.


  2. Effect of the program Computerized Mirror Therapy (CMT) + transcranial Direct Current Stimulation (tDCS) improving activities of the upper limb - measured by Frenchay arm test [ Time Frame: Day 70 ]

    To evaluate the effect of the program Computerized Mirror Therapy (CMT) + transcranial Direct Current Stimulation (tDCS) improving activities of the upper limb.

    It is will be measured by Frenchay arm test.


  3. occurrence of epileptic seizure [ Time Frame: Day 40 ]
    Measure of tolerance of the program Intensive Visual Simulation 3 (IVS3) + transcranial Direct Current Stimulation (tDCS) by the occurrence of epileptic seizure report by adverse event and serious adverse events.

  4. occurrence of Anxiety crisis [ Time Frame: Day 40 ]
    Measure of tolerance of the program Intensive Visual Simulation 3 (IVS3) + transcranial Direct Current Stimulation (tDCS) by the occurrence of anxiety crisis report by adverse event and serious adverse events.

  5. Tolerance Assessment Questionnaire [ Time Frame: Up to day 70 ]
    Analysis the results of the Tolerance Assessment Questionnaire.

  6. Evaluation of the program by Goal Attainment Scaling (GAS) [ Time Frame: Day 40 ]
    Analysis of evaluation of the program by Goal Attainment Scaling (GAS) results.

  7. Evaluation of the program by Goal Attainment Scaling (GAS) [ Time Frame: Day 70 ]
    Analysis of evaluation of the program by Goal Attainment Scaling (GAS) results.

  8. Quantitative improvement of the deficiencies - Fugl-Meyer test [ Time Frame: Day 40 ]
    Measure of the quantitative improvement of the deficiencies by analysis of Fugl-Meyer test results.

  9. Quantitative improvement of the deficiencies - Fugl-Meyer test [ Time Frame: Day 70 ]
    Measure of the quantitative improvement of the deficiencies by analysis of Fugl-Meyer test results.

  10. Abilities to perform several activities - Abilhand questionnaire [ Time Frame: Day 40 ]
    Analysis of abilities to perform several activities in the daily life by Abilhand questionnaire results.

  11. Abilities to perform several activities - Abilhand questionnaire [ Time Frame: Day 70 ]
    Analysis of abilities to perform several activities in the daily life by Abilhand questionnaire results.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Patient with first ischemic or hemorrhagic stroke for less than one year, having not recidivated since then and responsible for initially complete left or right hemiplegia
  • Modified Frenchay arm test score <70 (/ 100)
  • Without a neurological history other than stroke
  • Having signed the written consent and affiliated or entitled to a social security scheme

Exclusion Criteria:

  • Patient with contraindications to transcranial Direct Current Stimulation (tDCS) or Transcranial Magnetic Stimulation (TMS) (brain metal implant, pacemaker, other implanted active medical device)
  • Patient who didn't have cerebral Magnetic Resonance Imaging (MRI) imaging during their stroke
  • With complete lesion of the primary motor cortex
  • With alcohol / drug dependence
  • With psychiatric illness, cognitive impairment, uncontrolled disease / epilepsy, malignant disease, severe renal or pulmonary disease
  • With a history of disabling associated disease
  • With cerebellar syndrome
  • Pregnancy

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03815266


Contacts
Layout table for location contacts
Contact: Pascal GIRAUX, PhD (0)477127756 ext +33 pascal.giraux@chu-st-etienne.fr
Contact: Florence RANCON, CRA (0)477829458 ext +33 florence.rancon@chu-st-etienne.fr

Locations
Layout table for location information
France
Chu Saint-Etienne Recruiting
Saint-Étienne, France
Principal Investigator: Pascal GIRAUX, PhD         
Sub-Investigator: Agnès CONDEMINE, MD         
Sub-Investigator: Bérénice ZAGORDA, MD         
Sponsors and Collaborators
Centre Hospitalier Universitaire de Saint Etienne
Investigators
Layout table for investigator information
Principal Investigator: Pascal GIRAUX, PhD CHU SAINT-ETIENNE

Layout table for additonal information
Responsible Party: Centre Hospitalier Universitaire de Saint Etienne
ClinicalTrials.gov Identifier: NCT03815266     History of Changes
Other Study ID Numbers: 1708098
2018-A01883-52 ( Other Identifier: ANSM )
First Posted: January 24, 2019    Key Record Dates
Last Update Posted: January 24, 2019
Last Verified: January 2019
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Keywords provided by Centre Hospitalier Universitaire de Saint Etienne:
transcranial Direct Current Stimulation (tDCS)
Computerized Mirror Therapy (CMT)
hemiparetic
Ischemic
stroke
Intensive Visual Simulation3 (IVS3)

Additional relevant MeSH terms:
Layout table for MeSH terms
Stroke
Cerebrovascular Disorders
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Vascular Diseases
Cardiovascular Diseases